| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $2.26B | +21.8% |
| Cost of Revenue | $581.0M | +6.4% |
| Gross Profit | $1.68B | +28.2% |
| R&D Expense | $656.0M | +5.8% |
| SG&A Expense | $450.0M | +10.0% |
| Operating Income | -$516.0M | +36.5% |
| Interest Expense | $8.0M | -27.3% |
| Pre-tax Income | -$337.0M | +57.9% |
| Income Tax | $18.0M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $334.0M | +26.5% |
| Short-term Investments | $1.87B | -19.3% |
| Accounts Receivable | $559.0M | +16.2% |
| Current Assets | $2.98B | -7.7% |
| Total Assets | $8.99B | -3.4% |
| Current Liabilities | $1.78B | +21.6% |
| Total Liabilities | $3.10B | -19.3% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $512.0M | +495.3% |
| Capital Expenditures | $8.0M | -33.3% |
| Investing Cash Flow | $441.0M | +439.2% |
| Financing Cash Flow | -$883.0M | -1939.6% |
| Free Cash Flow | $504.0M | +581.1% |
| +28.6% |
| Net Income | -$355.0M | +56.4% |
| EPS (Basic) | -$2.17 | +57.9% |
| EPS (Diluted) | -$2.17 | +57.9% |
| Stockholders' Equity |
| $5.89B |
| +7.7% |